Latest Private Placement News

Renergen Limited reported a near doubling of revenue driven by increased LNG production and prices, yet its loss after tax more than doubled due to commissioning costs and higher depreciation. The company has begun commercial liquid helium sales and is navigating funding challenges and ongoing litigation.

Control Bionics reports its strongest US revenue in years alongside Australia’s best quarter since 2022, propelled by new product launches and strategic investments.

Horizon Minerals reported steady gold production from its Boorara and Phillips Find projects, marking first gold pours under key milling agreements. The company also finalized its merger with Poseidon Nickel, adding critical processing infrastructure and boosting growth prospects.

I Synergy Group Limited has successfully completed a $90,000 private placement by issuing 22.5 million shares at an 18.81% discount, aiming to bolster its growth and working capital.

Harris Technology Group reported steady Q3 FY25 sales of $3.3 million alongside a modest operating cash outflow, while successfully raising $1.5 million to fuel expansion in refurbished electronics.

Southern Cross Gold Consolidated has announced a substantial C$120 million private placement to fund key development phases at its Sunday Creek Gold-Antimony Project, aiming to fast-track drilling, decline construction, and resource expansion.

Radiopharm Theranostics has bolstered its cash position with an $8 million placement from Lantheus Holdings, now its largest shareholder. New clinical data highlight promising advances in brain metastases detection and HER2-targeted radiopharmaceutical therapies.

Canterbury Resources Limited has completed a $125,000 capital raise through a private placement of 5 million shares, each accompanied by an option exercisable at $0.05 until the end of 2026.

Canterbury Resources has reported significant advances at its Briggs Copper Project, including enhanced metallurgical recoveries and a resource upgrade, underpinning a scoping study on track for mid-2025 completion.

Fletcher Building reported a challenging HY25 with a 7% revenue decline and a net loss of NZ$134 million, while executing a $700 million equity raise to strengthen its balance sheet and advancing significant cost reduction initiatives.

NeuRizer Ltd has completed a $200,000 private share placement, issuing over 133 million new shares to support working capital and advance its Urea Project.

DomaCom has raised $1.5 million through a private placement with MFL Properties, replacing a prior deal and reinforcing its financial footing to advance technology and investment solutions.